Concepedia

Author

Stephanie Seremetis

Novo Nordisk (Denmark)

Also Known As

Donna DiMichele, Marcus Carr, S Seremetis, S V Seremetis, S. SEREMETIS, S. Seremetis, S. V. SEREMETIS, S.V Seremetis, S.V. Seremetis, STEPHANIE SEREMETIS

74

Publications

2.6K

Citations

24

H-Index

59

Concepts

All Affiliations

Novo Nordisk (Denmark)New York University Langone Orthopedic HospitalNovo Nordisk (United States)Icahn School of Medicine at Mount SinaiFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
SS

About

Stephanie Seremetis is an author at Novo Nordisk (Denmark) specializing in medicine, hematology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

13

1.2K

2

Cell Biology

4

4

386

3

Health Sciences

1

1

507

4

Anesthesia

1

1

65

5

Epidemiology

1

1

55

Stephanie Seremetis

×

26

Publications

2.1K

Citations

19

H-Index

YearCitations

Childhood emotional abuse and neglect as predictors of psychological and physical symptoms in women presenting to a primary care practice

Ilyse L. Spertus, Rachel Yehuda, Cheryl M. Wong,

Child Abuse & Neglect

2003

507

Single 270 μg kg<sup>−1</sup>‐dose rFVIIa vs. standard 90 μg kg<sup>−1</sup>‐dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison

Guy Young, Frank Shafer, Percy Rojas,

Haemophilia

2007

155

Internalization of human immunodeficiency virus type I and other retroviruses by megakaryocytes and platelets

Dorothea Zucker‐Franklin, Stephanie Seremetis, ZY Zheng

Blood

1990

142

Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells.

Gabriel Núñez, M Seto, Stephanie Seremetis,

Proceedings of the National Academy of Sciences

1989

136

Biochemistry and expression of myelomonocytic antigens.

Sanna M. Goyert, Elisabetta Ferrero, Stephanie Seremetis,

The Journal of Immunology

1986

130

Pharmacokinetic analysis of plasma‐derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B

Bruce M. Ewenstein, J. Heinrich Joist, Amy D. Shapiro,

Transfusion

2002

100

Monoclonal antibodies to the human CSF-1 receptor (c-fms proto-oncogene product) detect epitopes on normal mononuclear phagocytes and on human myeloid leukemic blast cells

RA Ashmun, A. Thomas Look, WM Roberts,

Blood

1989

92

Transformation and Plasmacytoid Differentiation of EBV-Infected Human B Lymphoblasts by <i>ras</i> Oncogenes

Stephanie Seremetis, Giorgio Inghirami, Dario Ferrero,

Science

1989

90

High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase.

Stephanie Seremetis, Pier Giuseppe Pelicci, Antonio Tabilio,

The Journal of Experimental Medicine

1987

90

Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia <scp>A</scp>: safety and efficacy

Steven R. Lentz, Mudi Misgav, Margareth C. Ozelo,

Haemophilia

2013

83

Page 1